Form 4: Director Mary Murphy Conlin Receives BODI Stock Grant

Director Mary Murphy Conlin was granted 9,182 deferred restricted stock units by The Beachbody Company, Inc.

Summary

• Director Mary Murphy Conlin acquired 9,182 deferred restricted stock units (DSUs) on June 2, 2026.
• The grant was made under the company's director Deferred Compensation Plan.
• The DSUs vest on the earlier of the first anniversary of the grant date or the date of the next annual meeting, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to continued service with the company.

Future Outlook

The DSUs will vest on the earlier of the first anniversary of the grant date or the date of the next annual meeting, with payment occurring upon separation from service, death, disability, or a change in control.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to align leadership incentives with long-term shareholder value in the consumer health and fitness sector.

Comparison to Industry Standards

• The use of deferred restricted stock units for director compensation is consistent with standard practices for publicly traded companies of similar size.
• The vesting schedule aligns with typical annual meeting cycles observed in the industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 9,182 DSUs upon the earlier of the first anniversary or the next annual meeting.

Key Dates

Keywords

BODI, Beachbody, Director Compensation, Form 4, Equity Grant